Gabelli Funds’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-235,396
| Closed | -$2.43M | – | 1157 |
|
|
2023
Q2 | $2.43M | Sell |
235,396
-10,000
| -4% | -$103K | 0.02% | 617 |
|
|
2023
Q1 | $2.49M | Sell |
245,396
-35,000
| -12% | -$355K | 0.02% | 616 |
|
|
2022
Q4 | $2.79M | Hold |
280,396
| – | – | 0.02% | 586 |
|
|
2022
Q3 | $2.73M | Buy |
280,396
+180,000
| +179% | +$1.76M | 0.02% | 589 |
|
|
2022
Q2 | $975K | Hold |
100,396
| – | – | 0.01% | 861 |
|
|
2022
Q1 | $974K | Hold |
100,396
| – | – | 0.01% | 895 |
|
|
2021
Q4 | $970K | Hold |
100,396
| – | – | 0.01% | 918 |
|
|
2021
Q3 | $973K | Buy |
+100,396
| New | +$973K | 0.01% | 913 |
|